You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: RE34672


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE34672
Title: Pharmaceutical composition containing a stable modification of torasemide
Abstract:The present invention provides a process for the preparation of cystalline torasemide in the pure modification I (monoclinic, space group P2.sub.1 /c, melting point 162.degree. C.) from torasemide of modification II (monoclinic, space group P2/n, melting point 169.degree. C.), wherein a suspension of torasemide of modification II is stirred in water with the addition of a catalytic amount of modification I until the rearrangement is complete. The present invention also provides pharmaceutical compositions containing torasemide of modification I.
Inventor(s): Topfmeier; Fritz (Heidelberg, DE), Lettenbauer; Gustav (Lampertheim, DE)
Assignee: Boehringer Mannheim GmbH (Mannheim, DE)
Application Number:08/043,631
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of U.S. Patents: A Detailed Examination

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent scope, claims, and the broader patent landscape, using the context of U.S. patents as a framework. We will also touch on the specific example of U.S. Patent RE34672, though the detailed analysis will be more general due to the lack of specific information on this particular patent in the provided sources.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical aspect of patent law, as it determines what is protected and what is not. Two simple metrics often used to measure patent scope are independent claim length and independent claim count[3].

Independent Claim Length and Count

Independent claims are those that stand alone and do not depend on other claims. The length and number of these claims can indicate the scope of the patent. Generally, narrower claims (shorter length and fewer in number) are associated with a higher probability of grant and a shorter examination process. Conversely, broader claims can lead to longer examination processes and higher litigation costs[3].

Patent Claims and Their Significance

Patent claims define the boundaries of the invention and are the most critical part of a patent application. They must be clear, concise, and supported by the patent's description.

Types of Claims

  • Independent Claims: These claims define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

The Examination Process

The examination process at the USPTO involves evaluating the patent claims to ensure they meet the criteria of novelty, non-obviousness, and utility. The process can narrow the scope of patent claims through revisions and amendments, particularly if the initial claims are too broad[3][4].

Patent Landscape and Trends

The patent landscape is dynamic, influenced by various factors including technological advancements, legal precedents, and economic conditions.

Geographic and Sectoral Analysis

Patent data can be analyzed based on the residence of inventors or the ownership rights of the patents. This allows for insights into patterns and trends in patenting activity across different regions and economic sectors. For instance, the National Science Foundation's report on Science and Engineering Indicators provides detailed analyses of patenting activity by geography and sector[1].

International Patents and Priority Countries

International patents are often part of a family of related patents, with the priority country determined by the earliest priority document in the patent family. This method ensures that inventions are correctly attributed to their country of origin, even if multiple countries are involved in the patent family[1].

Legal Considerations and Disputes

Patent disputes often revolve around the scope and validity of claims.

Inherent Anticipation

A key legal concept is inherent anticipation, where a prior art patent is found to anticipate a later patent if it inherently discloses the claimed limitation. For example, in the case of Arbutus Biopharma Corporation v. Moderna, Inc., the Patent Trial and Appeal Board found that a prior art patent inherently anticipated the claims of a later patent due to the natural properties and processes described in the prior art[2].

Inventorship and Deceptive Intent

Correct inventorship is crucial for the validity of a patent. Errors in inventorship, especially those made with deceptive intent, can render a patent unenforceable. This highlights the importance of accurate and honest disclosure in patent applications[5].

The Role of Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuation-in-part (CIP) applications, can significantly impact the patent landscape. These procedures allow applicants to revise and expand their claims, potentially leading to multiple patents from a single progenitor application. This complicates the calculation of allowance rates but provides flexibility in the patent application process[4].

Key Takeaways

  • Patent Scope: Measured by independent claim length and count, narrower claims are generally more favorable.
  • Claims: Define the invention and must be clear, concise, and supported by the patent description.
  • Examination Process: Can narrow the scope of claims through revisions and amendments.
  • Geographic and Sectoral Analysis: Provides insights into patenting trends by region and sector.
  • International Patents: Attributed to the priority country based on the earliest priority document.
  • Legal Considerations: Inherent anticipation and correct inventorship are critical for patent validity.
  • Continuation Procedures: Allow for revisions and expansions of patent claims.

FAQs

What are the key metrics for measuring patent scope?

The key metrics for measuring patent scope include independent claim length and independent claim count. Narrower claims (shorter length and fewer in number) are generally associated with a higher probability of grant and a shorter examination process[3].

How does the examination process affect patent claims?

The examination process can narrow the scope of patent claims through revisions and amendments. Broader claims may lead to longer examination processes and higher litigation costs[3][4].

What is the significance of the priority country in international patents?

The priority country is determined by the earliest priority document in the patent family and is used to attribute the invention to its country of origin. This method ensures that inventions are correctly attributed even if multiple countries are involved[1].

Why is correct inventorship important in patent applications?

Correct inventorship is crucial because errors, especially those made with deceptive intent, can render a patent unenforceable. Accurate and honest disclosure is essential for the validity of a patent[5].

What are the different types of continuation procedures in patent applications?

Continuation procedures include Requests for Continued Examination (RCEs), continuation-in-part (CIP) applications, and divisional applications. These allow applicants to revise and expand their claims, potentially leading to multiple patents from a single progenitor application[4].

Sources

  1. National Science Foundation, Invention, Knowledge Transfer, and Innovation, Science and Engineering Indicators 2024: Technical Documentation, 2024.
  2. United States Court of Appeals for the Federal Circuit, Arbutus Biopharma Corporation v. Moderna, Inc., 2023.
  3. SSRN, Patent Claims and Patent Scope, 2016.
  4. Yale Journal of Law and Technology, What Is the Probability of Receiving a US Patent?, 2020.
  5. Oregon State University, Determining Inventorship for US Patent Applications, 2020.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE34672

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: RE34672

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3529529Aug 17, 1985

International Family Members for US Patent RE34672

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 49196 ⤷  Subscribe
Australia 573454 ⤷  Subscribe
Australia 6105586 ⤷  Subscribe
Canada 1307277 ⤷  Subscribe
Czechoslovakia 259891 ⤷  Subscribe
Czechoslovakia 8605945 ⤷  Subscribe
Czechoslovakia 9104199 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.